IP Library Granted Patent US 8,663,985
Granted Patent B2
US 8,663,985 · App. 13/098,498 · Granted Mar 4, 2014

Anchoring/capturing system for selecting or analyzing a CHO cell according to a product secreted by the CHO cell

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,663,985
App. No.
13/098,498
Granted
Mar 4, 2014
Kind
B2
Abstract

An anchoring/capturing system for selecting or analyzing a CHO cell according to a product secreted by the CHO cell is described. The anchoring/capturing system comprises a first antibody or a first antigen-binding fragment for anchoring to the extracellular surface of the CHO cell, and a second antibody or a second antigen-binding fragment for binding the secreted product. Uses and methods involving the anchoring/capturing system are provided.

Claims (21)

1. A Chinese hamster ovary (CHO) cell bound to an anchoring/capturing system for selecting or analyzing a CHO cell according to a product secreted by said CHO cell, comprising a first antibody or a first antigen-binding fragment that binds an extracellular surface target of said CHO cell and a second antibody or a second antigen-binding fragment that binds the secreted CHO cell product, wherein the first antibody or first antigen-binding fragment is covalently linked to the second antibody or second antigen-binding fragment.

2. A method for selecting or analyzing a Chinese hamster ovary (CHO) cell according to a product secreted by the CHO cell, comprising:

(a) binding an anchoring/capturing system to the surface of the CHO cell for capturing the secreted CHO cell product, wherein the anchoring/capturing system comprises

a first antibody or a first antigen-binding fragment that binds an extracellular surface target of the CHO cell, and

a second antibody or a second antigen-binding fragment for binding the secreted product, wherein the first antibody or first antigen-binding fragment is covalently linked to the second antibody or second antigen-binding fragment;

(b) culturing the cell under conditions wherein the product is secreted and is specifically bound to the second antibody or to the second antigen-binding fragment;

(c) labeling the secreted product with a detectable label; and

(d) selecting or analyzing the CHO cell on the basis of the bound and labeled secreted CHO cell product.

3. The method of claim 2 , wherein the cells having product bound to the second antibody or the second antigen-binding, fragment are not lysed as part of the selection or analysis.

4. The method of claim 2 , wherein the secreted product is a protein.

5. The method of claim 4 , wherein said protein comprises an antibody or witigen-binding fragment thereof.

6. The method of claim 2 , wherein the secreted product is an antibody selected from the group consisting of humanized antibodies, chimeric antibodies, human antibodies and antigen-binding fragments thereof.

7. The method of claim 2 , wherein the detectable label comprises at least one of magnetic particles, fluorophores, radioactive isotopes, haptens or chromophores.

8. The method of claim 2 , wherein the secreted product is a CD303 (BDCA-2) antibody or a fragment thereof.

9. A method for selecting or analyzing a Chinese hamster ovary (CHO) cell according to a CD303 (BDCA-2) antibody or a CD303-binding fragment thereof secreted by said CHO cell, comprising:

(a) binding an anchoring/capturing system to the surface of said CHO cell for capturing the secreted CD303 (BDCA-2) antibody or fragment thereof, wherein the anchoring/capturing system comprises

a first antibody or a first antigen-binding fragment that binds an extracelltaar surface target of said CHO cell, and

a second antibody or a second antigen-binding fragment for binding the secreted CD303 (BDCA-2) antibody or fragment thereof, wherein the first antibody or first antigen-binding fragment is covalently linked to the second antibody or second antigen-binding fragment;

(b) culturing the cell under conditions wherein the CD303 (BDCA-2) antibody or fragment thereof is secreted and is specifically bound to the second antibody or to the second antigen-binding fragment;

(c) labeling the secreted CD303 (BDCA-2) antibody or fragment thereof with a detectable label; and

(d) selecting or analyzing the CHO cell on the basis of the bound and labeled secreted CD303 (BDCA-2) antibody or fragment thereof product.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 29, 2019
From: MILTENYI BIOTEC GMBH
To: MILTENYI BIOTEC B.V. & CO. KG
Reel/Frame 051443/0669 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 2, 2011
From: MILTENYI, STEFAN; HOHER-PETERS, SUSANNE; WINKELS, MONIKA
To: MILTENYI BIOTEC GMBH
Reel/Frame 026206/0150 →